RECRUITING

Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Cognitive behavioral therapy (CBT) is a brief, efficient, and effective treatment for individuals with depressive/anxiety disorders. However, CBT is largely underutilized within the Department of Veterans Affairs due to the cost and burden of trainings necessary to deliver all of the related disorder-specific treatments (DSTs). Transdiagnostic Behavior Therapy (TBT), in contrast, is specifically designed to address numerous distinct disorders within a single protocol in Veterans with depressive/anxiety disorders. The proposed research seeks to evaluate the efficacy of TBT by assessing psychiatric symptomatology and related impairment outcomes in Veterans with social anxiety disorder and comorbid posttraumatic stress via a randomized controlled trial of TBT and an existing DST. Assessments will be completed at pre-, mid-, and post-treatment, and at 6-month follow-up. Process variables also will be investigated.

Official Title

A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans With Social Anxiety Disorder and Comorbid PTSD Symptomatology

Quick Facts

Study Start:2024-04-01
Study Completion:2027-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05858346

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must be Veterans and registered at Ralph H. Johnson Veterans Affairs Health Care System
  2. * Participants must be clearly competent to provide informed consent for research participation
  3. * Participants must meet DSM-5 criteria for social anxiety disorder
  4. * Participants must have clinically significant symptoms of comorbid posttraumatic stress
  1. * recent history (\< 2 months) of psychiatric hospitalization or a suicide attempt as documented in their medical record,
  2. * acute, severe illness or medical condition that likely will interfere with study procedures as documented in their medical record
  3. * recent start of new psychiatric medication(s) (\< 4 weeks),
  4. * primary diagnosis of a condition associated with psychotic symptoms, personality disorder, substance use disorder, or bipolar disorder.

Contacts and Locations

Study Contact

Daniel F Gros, PhD MA BS
CONTACT
(843) 789-6225
daniel.gros@va.gov
Lacey Bonner, MA
CONTACT
(843) 577-5011
lacey.bonner@va.gov

Principal Investigator

Daniel F Gros, PhD MA BS
PRINCIPAL_INVESTIGATOR
Ralph H. Johnson VA Medical Center, Charleston, SC

Study Locations (Sites)

Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, 29401-5703
United States

Collaborators and Investigators

Sponsor: VA Office of Research and Development

  • Daniel F Gros, PhD MA BS, PRINCIPAL_INVESTIGATOR, Ralph H. Johnson VA Medical Center, Charleston, SC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-01
Study Completion Date2027-10-31

Study Record Updates

Study Start Date2024-04-01
Study Completion Date2027-10-31

Terms related to this study

Additional Relevant MeSH Terms

  • Social Anxiety Disorder